| Verified against primary record | |
| Governing instrument | Real Decreto 81/2014 of 7 February 2014[3] |
|---|---|
| Prior authorisation requests (2023) | 10 received, 9 authorised, 1 refused[1] |
| Reimbursement requests (2023) | 10 received, 9 granted, 2 refused[1] |
| Amount reimbursed, authorised care (2023) | EUR 5,481[1] |
| Charging of patients insured elsewhere | The same tariffs as Spanish patients in comparable situations[3] |
| Statutory reporting duty | Regions must send the Ministry data on patient flows, financial impact, authorisations and reimbursements[3] |
| Independently reported | |
| Incoming patients under the Directive (2016) | 46,138, the highest in the European Union[2] |
| Bands apply only to the rows beneath them. The 2023 counts are claims made by Spanish insured persons for care obtained abroad, which is why they are so small beside the incoming total: care given to visitors in Spain arises overwhelmingly under the social security coordination Regulations rather than under the Directive. The reimbursement row does not balance, with nine granted and two refused against ten received, because the Commission records that requests may be decided in a later year than the one in which they arrive. No typical cost range is given because the decree sets charges by reference to published public and private tariffs rather than a price list for foreign patients. | |
Medical tourism in Spain presents the sharpest contrast in European cross-border healthcare data. Spain has been the largest recipient of incoming patients in the European Union, yet in reference year 2023 it reported just ten requests for prior authorisation and ten requests for reimbursement under the cross-border healthcare Directive, with a total of 5,481 euro reimbursed. The two facts are not in conflict: they measure different legal routes, and almost all of the care foreigners receive in Spain travels along the route Spain barely reports on.
Two routes, one of them dominant
The European Court of Auditors recorded Spain as the member state receiving the most incoming patients under the cross-border arrangements in 2016, at 46,138, ahead of Portugal at 32,895 and Belgium at 27,457. Across the Union about 200,000 patients a year used the Directive, fewer than 0.05 per cent of EU citizens, and spending under it amounted to roughly 0.004 per cent of the Union’s healthcare budget.[2]
Set against that, Spain’s own return to the Commission for reference year 2023 records ten prior authorisation requests, of which nine were authorised and one refused, and ten reimbursement requests, of which nine were granted and two refused, with 5,481 euro reimbursed for care subject to prior authorisation.[1]
The reconciliation lies in what each figure counts. A member state’s Directive return describes its own insured persons seeking care elsewhere, not foreigners arriving on its territory. Spain’s incoming flow consists largely of visitors who fall ill or need care during a stay, which is handled under the older social security coordination Regulations and the European Health Insurance Card, and of pensioners resident in Spain whose costs are met by their home states. Neither appears in the Directive figures.[1]
The Commission’s own flow analysis supports this reading. It names the movements from France to Spain and from Sweden and Norway to Spain as among the busiest reimbursement flows in the Union, which describes patients drawing on their home systems while in Spain rather than Spanish patients travelling out.[1]
The Spanish legal framework
Spain transposed the Directive by Real Decreto 81/2014 of 7 February 2014. It defines cross-border healthcare as care provided or prescribed in a member state other than the state of affiliation, and covers EU nationals, stateless persons and refugees insured under EU social security rules together with their family members and survivors, and certain third-country nationals.[3]
Spanish insured persons pay upfront and claim reimbursement afterwards, which applies where the coordination Regulation does not or where the patient asks for the decree to apply instead. Reimbursement is confined to services in the common portfolio of the National Health System or a regional complementary portfolio, is capped at what Spain would have paid domestically and at the actual cost of care, and excludes related costs such as travel. Patients must satisfy the same conditions as for domestic care, including a prior assessment by a primary care doctor where one would be required at home.[3]
Prior authorisation applies to treatments listed in the decree’s second annex, decided by the regional authority, the national health management institute or the relevant civil servants’ mutual society. Refusal grounds include that the care is available in Spain within a medically justifiable time. Decisions are due within 45 days, and silence can operate as approval. Reimbursement claims must be filed within three months of payment, with decisions due within three months and silence again capable of counting as approval.[3]
Under the Directive itself, the member state of affiliation must reimburse cross-border care where the treatment is among the benefits it covers domestically, capped at the level of costs it would have assumed and not exceeding the actual cost received, and prior authorisation may be required only for care subject to planning requirements involving an overnight stay or highly specialised and cost-intensive infrastructure, for treatments carrying a particular risk, and for providers raising serious quality or safety concerns.[5]
Patients arriving from elsewhere
For patients insured in other member states who are treated in Spain, the decree sets out information rights through the national contact point and providers, access to complaint and damages procedures under Spanish law, continuity-of-care measures, and non-discrimination on grounds of nationality.[3]
On price, such patients pay the same tariffs as Spanish patients in comparable situations: public providers apply their published public prices and private providers their published tariffs. Prescriptions issued under the Directive carry a distinguishing code, and under that code the user pays the full amount. The Ministry may set access conditions for planning reasons after reporting to the body coordinating the regions, and any such conditions must be published by the contact point.[3]
The national contact point sits within the Ministry’s citizen information unit and is required to distinguish rights under the decree from rights under the coordination Regulations, a distinction the European Court of Auditors found fewer than half of national contact points across the Union actually explained.[3]
A reporting duty and a small return
The decree creates an explicit statistical obligation. Regional health services, the national health management institute and the civil servants’ mutual societies must send the Ministry data on patient flows, financial impact, prior authorisations and reimbursements, which the Ministry passes to the European Commission. A committee of the body coordinating the regions was to review patient flows and financial aspects during the first year and periodically thereafter.[3]
That machinery exists, and the figures it produced for 2023 are nonetheless among the smallest in the Union. Whether this reflects genuinely negligible use of the Directive by Spanish patients, or incomplete regional reporting, cannot be determined from the published figures alone.
Separately, Eurostat maintains a collection of hospital discharges of non-residents, with tables for in-patients, day cases, bed days and average length of stay, reporting country of residence for non-resident patients where member states can supply it. Individual cell values for Spain were not retrievable for this article.[4]
Limits of the evidence
No official Spanish count of foreign patients treated in Spain was located for this article, and the figures above should not be read as one. The 2016 incoming total is seven years older than the 2023 claim counts and comes from a different source, so the two must not be treated as a series. Privately funded treatment of foreign patients, which is what commercial usage most often means by medical tourism in Spain, appears in none of these sources.
See also
- Cross-border healthcare, and the two legal routes that explain Spain’s figures
- Healthcare for international retirees, a substantial part of the demand Spain meets
- Emergency healthcare abroad, the category most incoming care in Spain falls into
- Medical tourism in Portugal, the second largest recipient on the same measure
- Inbound medical tourism, the direction Spain leads on but does not report
References
- European Commission, Directorate-General for Health and Food Safety. Data on cross-border patient healthcare following Directive 2011/24/EU, reference year 2023. 15 May 2025. Verified against primary record: the report was opened and the Spanish rows for prior authorisation and reimbursement and the amount reimbursed, the named reimbursement flows into Spain from France, Sweden and Norway, and the caveat that requests may be decided in a later year were read directly. Retrieved 23 October 2026.
- European Court of Auditors. Special Report 07/2019: EU actions for cross-border healthcare. 2019. Verified against primary record: the report was opened and the 2016 incoming patient figures for Spain, Portugal and Belgium, the Union-wide annual patient estimate and spending share, and the finding on national contact points explaining the two routes were read. Retrieved 23 October 2026.
- Kingdom of Spain. Real Decreto 81/2014, de 7 de febrero. Boletin Oficial del Estado number 34, 8 February 2014. Verified against primary record: the decree was opened and the definitions, the pay-and-reclaim mechanism, the reimbursement caps and conditions, the prior authorisation annex and refusal grounds, the 45-day and three-month time limits with silence operating as approval, the charging rule for patients insured elsewhere, the prescription code requiring full payment, the national contact point and its duty to distinguish the two routes, and the reporting duties on regional services were read directly. Retrieved 23 October 2026.
- Eurostat. Hospital discharges and length of stay for inpatient and curative care (hlth_hosd), reference metadata. Last updated 15 December 2025. Verified against primary record: the metadata page was opened and the non-resident definition, the statement that country of residence is reported, and the list of non-resident tables were read. Retrieved 23 October 2026.
- European Parliament and Council. Directive 2011/24/EU, Chapter III, Articles 7 and 8. 9 March 2011. Verified against primary record: the chapter text was opened and the reimbursement rule in Article 7 and the three permitted grounds for prior authorisation in Article 8(2) were read. Retrieved 23 October 2026.
Sourcing note: this entry uses only official sources. The apparent contradiction between Spain’s large incoming patient total and its very small Directive claim counts is explained rather than resolved by selecting one figure, because the two measure different legal routes and different directions of travel. The two figures are deliberately not presented as a series. No official Spanish count of foreign patients treated in Spain was located, and none has been estimated. The Eurostat non-resident collection is cited for its definitions and structure only; its cell values could not be retrieved.